Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis
Franck Carbonnel(Université Paris-Saclay), Gaëlle Brillaut, Jean‐Frédéric Colombel(Mount Sinai Hospital), Olivier Dewit, Arnaud Bourreille(European CanCer Organisation), Fabrizio Bossa(Istituti di Ricovero e Cura a Carattere Scientifico), Laurent Peyrin‐Biroulet(Délégation Centre-Est), Véred Abitbol(Hôpital Cochin), Silvio Danese(IRCCS Ospedale San Raffaele), Hélène Sarter(Lille Inflammation Research International Center), Gottfried Novacek(Medical University of Vienna), Martti Färkkilâ(University of Helsinki), Édouard Louis(Centre Hospitalier Universitaire de Liège), Mathurin Fuméry(Centre Hospitalier Universitaire Amiens-Picardie), Pierre Michetti(University of Bern), Yoram Bouhnik(Clinique Ambroise Paré), Julie Demolin, Dominique Deplanque(Inserm), Philippe Seksik(Inserm), Patricia Détré, Georgia Malamut(Délégation Paris 5), Hédia Brixi(Hôpital Robert-Debré), Maria Nachury(Centre Hospitalier Universitaire de Lille), Baya Coulibaly, Konstantinos H. Katsanos(University of Ioannina), Gilles Bommelaer(Fondation FondaMental), Walter Reinisch(Medical University of Vienna), Jacques Moreau(Centre Hospitalier Universitaire de Toulouse), Xavier Roblin(Centre Hospitalier Universitaire de Saint-Étienne), Jérôme Filippi(Centre Hospitalier Universitaire de Nice), David Laharie(Université de Bordeaux)
Cited by 144
Related Papers
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2005|3.9k
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k